Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Closing Bell 18 November

Jessica Amir
November 18, 2019

Morning Bell 18 November

Bell Direct
November 18, 2019

Morning Bell 15 November

Bell Direct
November 15, 2019

Morning Bell 14 November

Bell Direct
November 14, 2019

Morning Bell 12 November

Bell Direct
November 12, 2019

Morning Bell 11 November

Bell Direct
November 11, 2019

Morning Bell 8 November

Bell Direct
November 8, 2019

Morning Bell 4 November

Bell Direct
November 4, 2019

Morning Bell 1 November

Bell Direct
November 1, 2019

Morning Bell 1 November

Bell Direct
November 1, 2019

ETF series: S&P Dow Jones Indices

Bell Direct
October 31, 2019